Personal information

No personal information available

Activities

Works (20)

Data-driven epidemiologic approach to conducting site feasibility for a global phase III tuberculosis vaccine clinical trial

PLOS Global Public Health
2023-11-08 | Journal article
Part of ISSN: 2767-3375
Contributors: Wai-Ling Mui; Falgunee Parekh; 0000-0003-2304-579X; Joy Toro; Taylor Craig; Maggwa; Alexander C Schmidt; Alemnew F. Dagnew; Craig Penz; Ghiorghis Belai
Source: Self-asserted source
Alemnew F Dagnew

Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials

Pain
2023-04 | Journal article
Part of ISSN: 0304-3959
Part of ISSN: 1872-6623
Contributors: Joon Hyung Kim; Robert Johnson; Martina Kovac; Anthony L. Cunningham; Mohamed Amakrane; Keith M. Sullivan; Alemnew F. Dagnew; Desmond Curran; Anne Schuind
Source: Self-asserted source
Alemnew F Dagnew

End-point definition and trial design to advance tuberculosis vaccine development

European Respiratory Review
2022-06-30 | Journal article | Author
Part of ISSN: 0905-9180
Part of ISSN: 1600-0617
Contributors: Alberto L. Garcia-Basteiro; Richard G. White; Dereck Tait; Alexander C. Schmidt; Molebogeng X. Rangaka; Matthew Quaife; Elisa Nemes; Robin Mogg; Philip C. Hill; Rebecca C. Harris et al.
Source: Self-asserted source
Alemnew F Dagnew

Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview

Human Vaccines & Immunotherapeutics
2021-11-02 | Journal article
Contributors: Alemnew F. Dagnew; Peter Vink; Mamadou Drame; David O. Willer; Bruno Salaun; Anne E. Schuind
Source: check_circle
Crossref

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine

The Journal of Infectious Diseases
2021-10-13 | Journal article
Contributors: Alemnew F Dagnew; Nicola P Klein; Caroline Hervé; George Kalema; Emmanuel Di Paolo; James Peterson; Bruno Salaun; Anne Schuind
Source: check_circle
Crossref

No consistent evidence of decreased exposure to varicella-zoster virus among older adults in countries with universal varicella vaccination

The Journal of Infectious Diseases
2021-10-05 | Journal article
Part of ISSN: 0022-1899
Part of ISSN: 1537-6613
Source: Self-asserted source
Alemnew F Dagnew

Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice

Human Vaccines & Immunotherapeutics
2021-08-18 | Journal article
Part of ISSN: 2164-5515
Part of ISSN: 2164-554X
Source: Self-asserted source
Alemnew F Dagnew

Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials

Drug Safety
2021-07 | Journal article
Part of ISSN: 0114-5916
Part of ISSN: 1179-1942
Source: Self-asserted source
Alemnew F Dagnew

Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials

Rheumatology
2021-03-02 | Journal article
Contributors: Alemnew F Dagnew; Debora Rausch; Caroline Hervé; Toufik Zahaf; Myron J Levin; Anne Schuind
Source: check_circle
Crossref

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.

The Lancet. Infectious diseases
2019-08 | Journal article
Contributors: Dagnew AF; Ilhan O; Lee WS; Woszczyk D; Kwak JY; Bowcock S; Sohn SK; Rodriguez Macías G; Chiou TJ; Quiel D et al.
Source: Self-asserted source
Alemnew F Dagnew via Europe PubMed Central

Medical Conditions at Enrollment do not Impact Efficacy and Safety of the Adjuvanted Recombinant Zoster Vaccine: a Pooled Post-Hoc Analysis of two Parallel Randomized Trials.

Human vaccines & immunotherapeutics
2019-06 | Journal article
Contributors: Oostvogels L; Heineman TC; Johnson RW; Levin MJ; McElhaney JE; Van den Steen P; Zahaf T; Dagnew AF; Chlibek R; Diez-Domingo J et al.
Source: Self-asserted source
Alemnew F Dagnew via Europe PubMed Central
grade
Preferred source (of 2)‎

149. Immunogenicity, Safety, and Post-hoc Efficacy Assessment of the Adjuvanted Recombinant Zoster Vaccine in Adults with Hematologic Malignancies: A Phase 3, Randomized Clinical Trial.

Open Forum Infectious Diseases
2018-11 | Journal article
Contributors: Dagnew AF; Ilhan O; Lee W; Woszczyk D; Kwak J; Bowcock S; Sohn SK; Rodriguez Macías G; Chiou T; Quiel D et al.
Source: Self-asserted source
Alemnew F Dagnew via Europe PubMed Central

A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area.

Trials
2018-01 | Journal article
Contributors: Hussein J; Zewdie M; Yamuah L; Bedru A; Abebe M; Dagnew AF; Chanyalew M; Yohannes AG; Ahmed J; Engers H et al.
Source: Self-asserted source
Alemnew F Dagnew via Europe PubMed Central

Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2015-11 | Journal article
Contributors: Hartvickson R; Cruz M; Ervin J; Brandon D; Forleo-Neto E; Dagnew AF; Chandra R; Lindert K; Mateen AA
Source: Self-asserted source
Alemnew F Dagnew via Europe PubMed Central

Immunogenicity and safety of concomitant administration of a combined hepatitis A/B vaccine and a quadrivalent meningococcal conjugate vaccine in healthy adults.

Journal of travel medicine
2014-12 | Journal article
Contributors: Alberer M; Burchard G; Jelinek T; Reisinger EC; Meyer S; Forleo-Neto E; Dagnew AF; Arora AK
Source: Self-asserted source
Alemnew F Dagnew via Europe PubMed Central

Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2014-10 | Journal article
Contributors: Lee HJ; Chung MH; Kim WJ; Hong YJ; Choi KM; Lee J; Oh CE; Welsch JA; Kim KH; Hong KB et al.
Source: Self-asserted source
Alemnew F Dagnew via Europe PubMed Central

Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.

Journal of travel medicine
2014-10 | Journal article
Contributors: Alberer M; Burchard G; Jelinek T; Reisinger E; Beran J; Hlavata LC; Forleo-Neto E; Dagnew AF; Arora AK
Source: Self-asserted source
Alemnew F Dagnew via Europe PubMed Central

Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: a randomized, open-label, multi-center study.

Travel medicine and infectious disease
2014-05 | Journal article
Contributors: Alberer M; Burchard G; Jelinek T; Reisinger E; Beran J; Meyer S; Forleo-Neto E; Gniel D; Dagnew AF; Arora AK
Source: Self-asserted source
Alemnew F Dagnew via Europe PubMed Central

Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth.

BMC research notes
2012-08 | Journal article
Contributors: Dagnew AF; Hussein J; Abebe M; Zewdie M; Mihret A; Bedru A; Chanyalew M; Yamuah L; Medhin G; Bang P et al.
Source: Self-asserted source
Alemnew F Dagnew via Europe PubMed Central

Variation in reported neonatal group B streptococcal disease incidence in developing countries.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2012-04 | Journal article
Contributors: Dagnew AF; Cunnington MC; Dube Q; Edwards MS; French N; Heyderman RS; Madhi SA; Slobod K; Clemens SA
Source: Self-asserted source
Alemnew F Dagnew via Europe PubMed Central

Peer review (3 reviews for 1 publication/grant)

Review activity for The lancet. (3)